New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareGonadorelin vs Follistatin

Gonadorelin vs Follistatin

Side-by-side comparison of key properties, dosing, and research.

Sexual Health & LibidoAnti-Aging & Longevity
Gonadorelin
Anabolic & IGF
Follistatin
Summary
Gonadorelin is the synthetic form of endogenous GnRH (gonadotropin-releasing hormone). It stimulates the pituitary to release LH and FSH, maintaining testicular function and testosterone production. Widely used alongside TRT to prevent testicular atrophy and preserve fertility.
Follistatin is an endogenous glycoprotein that acts as a potent inhibitor of myostatin and activin, two proteins that limit muscle growth. By binding and neutralizing myostatin, follistatin removes the primary brake on skeletal muscle hypertrophy, enabling significant muscle growth beyond normal physiological limits. It is distinct from its isoforms Follistatin 315 and Follistatin 344 in tissue distribution and binding affinity.
Half-Life
~2–4 minutes (extremely short); pulsatile dosing required to avoid desensitization
~3–5 hours (endogenous form)
Admin Route
SubQ, Intranasal
IM, SubQ
Research
Typical Dose
100 mcg
50–100 mcg per injection site
Frequency
Twice daily (every 12 hours)
Every other day or 2–3x per week
Key Benefits
  • Maintains testicular size during TRT
  • Preserves fertility and sperm production during testosterone use
  • Stimulates endogenous LH/FSH production
  • Maintains HPG axis function during exogenous hormone use
  • Used for HCG-free TRT protocols
  • Helps restart natural testosterone production (PCT)
  • Potent myostatin inhibition enabling supraphysiological muscle growth
  • Increases skeletal muscle mass and fiber size
  • May accelerate recovery from muscle injury
  • Potential benefits in muscular dystrophy and sarcopenia
  • Synergistic with IGF-1 and growth hormone in anabolic protocols
  • Animal studies show dramatic increases in muscle mass
  • Reduces muscle fibrosis in dystrophic models
Side Effects
  • Injection site reactions
  • Headache
  • Nausea at initiation
  • Tachycardia (rare)
  • +1 more
  • Potential for excessive muscle growth if doses are not controlled
  • FSH suppression with implications for fertility in women
  • Theoretical risk of cardiac hypertrophy with prolonged high-dose use
  • Limited human safety data available
  • +1 more
Stacks With